Cogora: The Agency – July digest 

The Cogora: The Agency team have been working on a range of projects this month.

The agenda for the upcoming 2024 European NeuroEndocrine Association (ENEA) conference has been finalised and design work for flyers and banners has kicked off. The team are poised and eager to receive the speaker’s slides for the conference. 

The team is preparing for ‘Pituitary Month’ by producing four short-form educational videos led by key opinion leaders (KOLs). The videos will focus on the basics of Cushing’s syndrome, the diagnostic challenges involved, and the relationship between the syndrome and the body’s circadian rhythm.     

Exciting progress has also been made on a brand-new journal article titled " Experience with PCR Testing for Enteric Bacteria and Viruses of Emergency Department Patients with Acute Gastroenteritis: Are There Implications for the Early Treatment of Clostridioides difficile Infection?’. Two new deep-dive articles on molecular testing techniques are also in the works.   

Fundamental work has also been conducted on a NICE abridged guidance on a new migraine preventative treatment following the publication of the much-anticipated evidence and guidance on the treatment.  

The team celebrated reaching a key milestone in developing a handbook on SGLT2 inhibitors focused on kidney disease. This achievement was marked by securing the first foreword from a KOL for the Nursing In Practice version of the booklet. 

Finally, the team received the fantastic news that NICE have approved the abridged guidance on a recently appraised treatment of wild-type or hereditary transthyretin amyloidosis in adults with cardiomyopathy. 

Check out what the team were up to in June for more examples of how Cogora: The Agency, a leading Healthcare Communications Agency, delivers consistent value for its clients. For more information, please contact us.